Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ENVX
ENVX logo

ENVX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
6.467
Open
6.390
VWAP
6.29
Vol
5.18M
Mkt Cap
1.37B
Low
6.090
Amount
32.61M
EV/EBITDA(TTM)
--
Total Shares
217.22M
EV
1.39B
EV/OCF(TTM)
--
P/S(TTM)
40.59
Enovix Corporation is a global high-performance battery company. The Company designs, develops, manufactures, and commercializes lithium-ion (Li-ion) battery cells that increase the amount of energy density and storage capacity relative to conventional battery cells. In addition to designing its batteries, it also develops the advanced manufacturing processes needed to produce its batteries in high volume. It targets a smaller group of large customers that require custom cells. Its technology roadmap is built around a structured progression of battery nodes, with each new generation, such as the EX-1M, EX-2M, EX-3M and so on. The Company, through Routejade, Inc. (Routejade), supplies batteries for wearables, medical devices, headsets, activity trackers, and industrial equipment. Routejade offers product categories, including PD series, FLPB and ASDB series, and SLPB series. The PD series consists of rechargeable coin cells commonly used in healthcare and IoT applications.
Show More

Events Timeline

(ET)
2026-02-25
16:40:00
Company Sees Q1 Revenue of $6.5M-$7.5M
select

News

NASDAQ.COM
8.0
04-06NASDAQ.COM
Surge in Options Trading Volume for Enovix and Clover Health
  • Enovix Options Volume: Enovix Corp saw options trading volume of 47,349 contracts, equivalent to approximately 4.7 million shares, representing about 85% of its average daily trading volume of 5.6 million shares over the past month, indicating heightened market interest in its future performance.
  • High-Frequency Trading: Notably, the $7 strike call option expiring on October 16, 2026, has seen 11,736 contracts traded today, representing around 1.2 million underlying shares, suggesting increased investor expectations for Enovix's stock price appreciation.
  • Clover Options Activity: Clover Health Investments Corp recorded options trading volume of 45,122 contracts, approximately 4.5 million shares, which accounts for about 80% of its average daily trading volume of 5.6 million shares over the past month, reflecting active market interest in its stock.
  • Clover High-Frequency Trading: The $2 strike call option expiring on April 10, 2026, has seen 13,076 contracts traded today, representing about 1.3 million underlying shares, indicating optimistic sentiment among investors regarding Clover's future performance.
Benzinga
6.0
03-12Benzinga
Wall Street Analysts Adjust Ratings
  • Analyst Rating Updates: Top Wall Street analysts have adjusted their ratings on several companies, including upgrades, downgrades, and initiations, reflecting the latest market views and expectations for these firms.
  • Market Dynamics Observation: While specific company names are not disclosed, changes in analyst ratings typically influence investor confidence, thereby directly impacting the market performance of the related stocks.
  • Investor Decision Reference: Investors considering buying FPI stock can refer to these analyst rating changes to make more informed investment decisions, although specific recommendations are not provided.
  • Transparent Information Source: Benzinga's market news and data aim to provide investors with comprehensive insights into analyst rating changes, helping them better understand market dynamics.
moomoo
4.0
03-12moomoo
ENOVIX CORP: BOFA GLOBAL RESEARCH STARTS COVERAGE WITH NEUTRAL RATING AND $6 PRICE TARGET
  • Company Overview: Enovix Corp is a company focused on advanced battery technology and research initiatives.

  • Research Coverage: BofA Global Research has initiated coverage on Enovix Corp with a neutral rating.

  • Price Objective: The price objective set by BofA for Enovix Corp is $6.

  • Market Implications: The neutral rating suggests a cautious outlook on the company's stock performance in the near term.

NASDAQ.COM
2.0
03-03NASDAQ.COM
Enovix Corp Shares Enter Oversold Territory
  • Oversold Signal: Enovix Corp (Ticker: ENVX) hit an RSI of 29.1 during Tuesday's trading, indicating an oversold condition as shares dipped to $5.05, suggesting that the recent heavy selling may be exhausting, prompting bullish investors to seek buying opportunities.
  • Market Comparison: Compared to the S&P 500 ETF (SPY) with an RSI of 43.4, ENVX's oversold status may attract bullish investors, particularly given the stronger overall market performance, indicating potential rebound opportunities due to its undervaluation.
  • Historical Performance Analysis: ENVX's 52-week low is $4.6112 and the high is $16.49, with the last trade at $5.07, reflecting significant price volatility within this range, potentially offering investors a chance to buy at a low price point.
  • Investor Sentiment: While the current stock price is low, investors should carefully assess market sentiment and technical indicators to avoid impulsive decisions in an uncertain market environment, especially as overall market sentiment remains positive.
seekingalpha
9.5
02-26seekingalpha
Enovix Corporation Q4 2025 Earnings Call Insights
  • Significant Revenue Growth: Enovix reported Q4 2025 revenue of $11.3 million, a 16% year-over-year increase that exceeded the upper guidance of $10.5 million, reflecting continued strength in defense and industrial shipments, thereby enhancing the company's competitive position in the market.
  • Strong Liquidity Position: The company ended the quarter with $621 million in cash, cash equivalents, and marketable securities, providing ample funding for commercialization efforts, while a newly authorized share repurchase program further bolsters investor confidence.
  • Leadership Optimization: Kihong Park has taken the helm of global manufacturing, and Ed Casey has joined to lead advanced manufacturing engineering, strengthening operational leadership to ensure manufacturing execution as the company prepares for high-volume production, positioning itself advantageously in the rapidly growing smart eyewear market.
  • Broad Market Outlook: Management anticipates that the total addressable market for smart eyewear batteries could exceed $400 million by 2030, indicating the company's strategic positioning in emerging markets and long-term growth potential, although the commercialization of smartphone-related revenue still hinges on passing stringent qualification standards.
stocktwits
9.5
02-26stocktwits
Enovix Exceeds Q4 Expectations Amid Caution
  • Strong Performance: Enovix reported fourth-quarter revenue of $11.3 million, a 16.5% increase year-over-year, surpassing Wall Street's expectations of $10.3 million, indicating robust demand for its batteries despite a more than 3% drop in after-hours trading.
  • Production Expansion Challenges: The company posted a quarterly loss of $0.16 per share, better than the expected loss of $0.24, yet investor caution regarding manufacturing ramp-up persists, contributing to a 32% decline in stock price over the past year.
  • Smartphone Qualification: CEO Raj Talluri noted ongoing engagement with seven of the top eight global smartphone brands, focusing on advancing the AI-1 platform qualification, particularly with Honor, aiming for completion in Q3 2025, which is crucial for future production planning.
  • Shifting Market Sentiment: Retail sentiment on Enovix shifted from 'bearish' to 'extremely bullish', with message volumes on Stocktwits surging 265%, although some users expressed concerns about potential failures in Honor's qualification process, highlighting mixed market perceptions about the company's future prospects.
Wall Street analysts forecast ENVX stock price to rise
9 Analyst Rating
Wall Street analysts forecast ENVX stock price to rise
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
10.00
Averages
19.00
High
25.00
Current: 0.000
sliders
Low
10.00
Averages
19.00
High
25.00
BofA
Neutral
initiated
$6
AI Analysis
2026-03-12
Reason
BofA
Price Target
$6
AI Analysis
2026-03-12
initiated
Neutral
Reason
BofA initiated coverage of Enovix with a Neutral rating and $6 price target.
BofA
Ruplu Bhattacharya
Neutral
initiated
$6
2026-03-12
Reason
BofA
Ruplu Bhattacharya
Price Target
$6
2026-03-12
initiated
Neutral
Reason
As previously reported, BofA analyst Ruplu Bhattacharya initiated coverage of Enovix with a Neutral rating and $6 price target. Enovix is "leading the charge" in developing next-generation high energy density lithium ion batteries and aims to bring a 100% silicon-anode battery to market for the first time, the analyst tells investors. While Enovix is demonstrating "technical milestones across multiple segments," the firm sees revenue potential and a large addressable market as balanced by early manufacturing hurdles, long smartphone qualification periods, and expected negative margins and cash flow over coming years, the analyst added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ENVX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Enovix Corp (ENVX.O) is 0.00, compared to its 5-year average forward P/E of -14.18. For a more detailed relative valuation and DCF analysis to assess Enovix Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-14.18
Current PE
0.00
Overvalued PE
-3.95
Undervalued PE
-24.40

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-9.19
Current EV/EBITDA
184.76
Overvalued EV/EBITDA
36.19
Undervalued EV/EBITDA
-54.57

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
262.03
Current PS
10.40
Overvalued PS
523.21
Undervalued PS
0.84

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what is a good stock to buy under $10
Intellectia · 26 candidates
Market Cap: >= 1000.00MPrice: <= $10.00Weekly Average Turnover: >= 2,000,000Pe Ttm: <= 15Annual Revenue Yoy Growth: >= 20.0%
Ticker
Name
Market Cap$
top bottom
IBRX logo
IBRX
Immunitybio Inc
6.82B
RIG logo
RIG
Transocean Ltd
5.10B
DNN logo
DNN
Denison Mines Corp
3.36B
PTEN logo
PTEN
Patterson-UTI Energy Inc
2.79B
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
2.40B
GENI logo
GENI
Genius Sports Ltd
2.32B
good stock picks under $10
Intellectia · 10 candidates
Market Cap: >= 1.50BPrice: <= $10.00Weekly Average Turnover: >= 3,000,000Pe Ttm: <= 12Annual Revenue Yoy Growth: >= 20.0%
Ticker
Name
Market Cap$
top bottom
IBRX logo
IBRX
Immunitybio Inc
6.82B
RIG logo
RIG
Transocean Ltd
5.10B
DNN logo
DNN
Denison Mines Corp
3.36B
PTEN logo
PTEN
Patterson-UTI Energy Inc
2.79B
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
2.40B
GENI logo
GENI
Genius Sports Ltd
2.32B

Whales Holding ENVX

E
Electron Capital Partners, LLC
Holding
ENVX
+11.19%
3M Return
C
Centerbook Partners LP
Holding
ENVX
-1.69%
3M Return
G
Granahan Investment Management, LLC
Holding
ENVX
-8.50%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Enovix Corp (ENVX) stock price today?

The current price of ENVX is 6.31 USD — it has decreased -0.79

What is Enovix Corp (ENVX)'s business?

Enovix Corporation is a global high-performance battery company. The Company designs, develops, manufactures, and commercializes lithium-ion (Li-ion) battery cells that increase the amount of energy density and storage capacity relative to conventional battery cells. In addition to designing its batteries, it also develops the advanced manufacturing processes needed to produce its batteries in high volume. It targets a smaller group of large customers that require custom cells. Its technology roadmap is built around a structured progression of battery nodes, with each new generation, such as the EX-1M, EX-2M, EX-3M and so on. The Company, through Routejade, Inc. (Routejade), supplies batteries for wearables, medical devices, headsets, activity trackers, and industrial equipment. Routejade offers product categories, including PD series, FLPB and ASDB series, and SLPB series. The PD series consists of rechargeable coin cells commonly used in healthcare and IoT applications.

What is the price predicton of ENVX Stock?

Wall Street analysts forecast ENVX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENVX is19.00 USD with a low forecast of 10.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Enovix Corp (ENVX)'s revenue for the last quarter?

Enovix Corp revenue for the last quarter amounts to 11.27M USD, increased 15.93

What is Enovix Corp (ENVX)'s earnings per share (EPS) for the last quarter?

Enovix Corp. EPS for the last quarter amounts to -0.16 USD, decreased -20.00

How many employees does Enovix Corp (ENVX). have?

Enovix Corp (ENVX) has 664 emplpoyees as of April 16 2026.

What is Enovix Corp (ENVX) market cap?

Today ENVX has the market capitalization of 1.37B USD.